Variant report

Variant	nsv886952
Chromosome Location	chr6:167805521-167832771
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:167823826..167826272-chr6:167829672..167831832,2	K562	blood:
2	chr6:167813417..167815135-chr6:167817698..167819518,2	K562	blood:
3	chr6:167818746..167821496-chr6:167831177..167833070,2	K562	blood:
4	chr6:167818746..167821496-chr6:167831177..167833070,2	K562	blood:
5	chr6:167813417..167815135-chr6:167817698..167819518,2	K562	blood:
6	chr6:167823826..167826272-chr6:167829672..167831832,2	K562	blood:
7	chr20:57615578..57617834-chr6:167831422..167833295,2	MCF-7	breast:
8	chr6:167662732..167663315-chr6:167819023..167819880,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TCP10-2	chr6:167822441-167822752	ucscGeneNc_uc003qvx_1
2	lnc-TCP10-2	chr6:167810373-167814438	ucscGeneNc_uc003qvx_1
3	lnc-TCP10-3	chr6:167825862-167825976	ucscGeneNc_uc003qvy_1
4	lnc-TCP10-2	chr6:167821589-167821728	ucscGeneNc_uc003qvx_1
5	lnc-TCP10-3	chr6:167826637-167827774	ucscGeneNc_uc003qvy_1
6	lnc-TCP10-3	chr6:167823155-167825466	ucscGeneNc_uc003qvy_1

No data

Variant related genes	Relation type
ENSG00000101166	chromatin interactions

Extended variants
information (count: 1299 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:1299 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374682565	chr6:167807216-167807217	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs376939203	chr6:167807228-167807229	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs115004847	chr6:167807249-167807250	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs184130201	chr6:167807300-167807301	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs563589021	chr6:167807310-167807311	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs9364928	chr6:167807356-167807357	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs552602528	chr6:167807357-167807358	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs570876160	chr6:167807385-167807386	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs9364929	chr6:167807418-167807419	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs531013812	chr6:167807419-167807420	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs145422799	chr6:167807469-167807470	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs565956077	chr6:167807477-167807478	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs536595388	chr6:167807481-167807482	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs190674946	chr6:167807482-167807483	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs9355637	chr6:167807484-167807485	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs182066403	chr6:167807487-167807488	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs55933210	chr6:167807525-167807526	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs9364930	chr6:167807544-167807545	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs35638680	chr6:167807557-167807558	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs541006894	chr6:167807578-167807579	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs151039873	chr6:167807595-167807596	ZNF genes & repeats Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs140912887	chr6:167807627-167807628	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs532479402	chr6:167807629-167807630	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs9457329	chr6:167807681-167807682	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs144483432	chr6:167807693-167807694	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs374712977	chr6:167807694-167807695	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs138404291	chr6:167807697-167807698	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs552010313	chr6:167807701-167807702	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs56678511	chr6:167807715-167807716	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs542159273	chr6:167807726-167807727	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs143847020	chr6:167807746-167807747	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs71004137	chr6:167807751-167807752	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs370368887	chr6:167807753-167807754	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs9364931	chr6:167807754-167807755	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs9355639	chr6:167807755-167807756	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs200776367	chr6:167807758-167807759	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs372065899	chr6:167807761-167807762	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs368370635	chr6:167807766-167807767	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs200444219	chr6:167807767-167807768	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs111242486	chr6:167807771-167807772	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs374026747	chr6:167807796-167807797	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs71004138	chr6:167807801-167807802	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs201916856	chr6:167807821-167807822	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs386409291	chr6:167807828-167807829	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs67682322	chr6:167807829-167807830	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs9457330	chr6:167807870-167807871	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs374064506	chr6:167807879-167807880	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs71004140	chr6:167807882-167807883	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs144679917	chr6:167807883-167807884	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs549864678	chr6:167807892-167807893	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:140 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167807200-167807400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr6:167807200-167807600	Enhancers	Rectal Smooth Muscle	rectum
3	chr6:167807400-167807600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr6:167807400-167809600	Bivalent Enhancer	HepG2	liver
5	chr6:167807600-167814400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr6:167808200-167808400	Enhancers	Fetal Lung	lung
7	chr6:167808400-167809000	Weak transcription	Fetal Lung	lung
8	chr6:167809000-167809800	Enhancers	Fetal Lung	lung
9	chr6:167809200-167812600	Enhancers	Liver	Liver
10	chr6:167809200-167812800	Enhancers	Fetal Intestine Small	intestine
11	chr6:167809400-167811800	Enhancers	Stomach Mucosa	stomach
12	chr6:167809400-167812800	Enhancers	Fetal Intestine Large	intestine
13	chr6:167809600-167810400	Flanking Bivalent TSS/Enh	HepG2	liver
14	chr6:167809800-167810400	Weak transcription	Fetal Lung	lung
15	chr6:167809800-167810400	Enhancers	Rectal Mucosa Donor 31	rectum
16	chr6:167810000-167810600	Enhancers	Pancreas	Pancrea
17	chr6:167810000-167811400	Enhancers	Gastric	stomach
18	chr6:167810400-167810600	Enhancers	Fetal Lung	lung
19	chr6:167810400-167810800	Flanking Active TSS	HepG2	liver
20	chr6:167810400-167811800	Enhancers	Spleen	Spleen
21	chr6:167810400-167814800	Weak transcription	Rectal Mucosa Donor 31	rectum
22	chr6:167810600-167811800	Weak transcription	Pancreas	Pancrea
23	chr6:167810800-167811600	Enhancers	HepG2	liver
24	chr6:167811000-167811800	Weak transcription	Lung	lung
25	chr6:167811200-167812200	Enhancers	Duodenum Mucosa	Duodenum
26	chr6:167811200-167812800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
27	chr6:167811600-167812400	Flanking Active TSS	HepG2	liver
28	chr6:167811800-167812000	Enhancers	Pancreas	Pancrea
29	chr6:167811800-167812600	Weak transcription	Spleen	Spleen
30	chr6:167812000-167812200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr6:167812000-167812200	Weak transcription	Pancreas	Pancrea
32	chr6:167812400-167813200	Enhancers	HepG2	liver
33	chr6:167812600-167812800	Enhancers	Spleen	Spleen
34	chr6:167812800-167814200	Weak transcription	Fetal Intestine Large	intestine
35	chr6:167812800-167814600	Weak transcription	Fetal Intestine Small	intestine
36	chr6:167812800-167815200	Weak transcription	Spleen	Spleen
37	chr6:167813600-167815400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr6:167814200-167815200	Enhancers	HepG2	liver
39	chr6:167814200-167816000	Enhancers	Fetal Intestine Large	intestine
40	chr6:167814400-167814600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr6:167814600-167815000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr6:167814600-167815800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
43	chr6:167814600-167816000	Enhancers	Fetal Intestine Small	intestine
44	chr6:167814800-167815800	Enhancers	Rectal Mucosa Donor 31	rectum
45	chr6:167815000-167815600	Enhancers	Rectal Mucosa Donor 29	rectum
46	chr6:167815000-167816000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr6:167815000-167817400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
48	chr6:167815200-167815400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr6:167815200-167815400	Enhancers	Spleen	Spleen
50	chr6:167815200-167815400	Flanking Active TSS	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links